Rnaseq

---

Unified rhombic lip origins of group 3 and group 4 medulloblastoma

Sept. 21, 2022 |  cancer   DNAsequencing   RNAseq   Methylation   ATACseq   single-cell   ChIPseq   First-author  

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma. Molecular cancer therapeutics

Aug. 2, 2022 |  cancer   RNAseq  

Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination

June 29, 2021 |  cancer   RNAseq   Methylation  

Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma

Jan. 27, 2021 |  cancer   DNAsequencing   RNAseq   Methylation   First-author  

Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03)

Jan. 6, 2021 |  cancer   DNAsequencing   RNAseq   Methylation  

Deconstructing sonic hedgehog medulloblastoma: molecular subtypes, drivers, and beyond

Dec. 1, 2020 |  cancer   DNAsequencing   RNAseq   Methylation  

DDX3X suppresses the susceptibility of hindbrain lineages to medulloblastoma

Aug. 24, 2020 |  cancer   DNAsequencing   RNAseq   Methylation  

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

Aug. 14, 2020 |  cancer   DNAsequencing   RNAseq   Methylation   First-author  

SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors

June 9, 2020 |  cancer   DNAsequencing   RNAseq   Methylation  

Germline elongator mutations in sonic hedgehog medulloblastoma

April 1, 2020 |  cancer   DNAsequencing   RNAseq   Methylation   Protein  

scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy

Dec. 20, 2019 |  cancer   RNAseq   single-cell  

Resolving medulloblastoma cellular architecture by single-cell genomics

July 24, 2019 |  cancer   DNAsequencing   RNAseq   Methylation   single-cell   First-author  

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

June 19, 2018 |  cancer   DNAsequencing   RNAseq   Methylation  

NRL and CRX define photoreceptor identity and reveal subgroup-specific dependencies in medulloblastoma

March 12, 2018 |  cancer   RNAseq  

Significance of duon mutations in cancer genomes

June 8, 2016 |  cancer   DNAsequencing   RNAseq